FBInvestor
Stocks / Casi Pharmaceuticals Inc
Institutional Ownership

Casi Pharmaceuticals Inc

CUSIP G1933S101ORD SHSCASIFQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon